PDF icon PDF herunterladen
Horm Metab Res 1985; 17(11): 607-609
DOI: 10.1055/s-2007-1013618
Clinical

© Georg Thieme Verlag, Stuttgart · New York

Androgen, Estrogen and Progestin Binding in Cytosols of Benign Gynecologic Tumors and Tumor-Like Lesions

R. Punnonen1 , K. Pettersson2 , R. Vanharanta3 , A. Lukola4
  • 1Department of Obstetrics and Gynecology, Turku University Central Hospital, Turku, Finland
  • 2Biochemical Laboratory of Wallac, Åbo Akademi, Turku, Finland
  • 3Department of Pathology, Turku University Central Hospital, Turku, Finland
  • 4Department of Biochemistry and Pharmacy, Åbo Akademi, Turku, Finland
Weitere Informationen

Publikationsverlauf

1983

1984

Publikationsdatum:
14. März 2008 (online)

Auch verfügbar aufeRef
 als PDF herunterladen  Lizenzen und Reprints
Preview

Summary

Specific androgen (Kd 0.27±0.06 nM), estrogen (Kd 0.19±0.04 nM) and progestin (Kd 0.22±0.07 nM) binding were investigated in benign gynecologic tumors and tumor-like lesions. The simultaneous presence of androgen and progestin receptors was a common finding. In one endo-metrioma, specific androgen, estrogen and progestin binding was observed simultaneously.

Key-Words:

Androgen - Estrogen and Progestin Receptors - Gynecologic Tumors